Castleark Management LLC Incyte Corp Transaction History

Castleark Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 16, 2022	SELL	$63.34 - $74.11 $105,144 - $123,022	-1,660 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$76.02 - $100.5 $67,657 - $89,445	-890 Reduced 34.9%	1,660 $135,000
Q2 2020 Aug 14, 2020	BUY	$74.18 - $108.93 $189,159 - $277,771	2,550 New	2,550 $265,000
Q1 2020 May 13, 2020	SELL	$63.18 - $85.97 $405,615 - $551,927	-6,420 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$73.04 - $95.72 $468,916 - $614,522	6,420 New	6,420 $561,000

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

Stay updated on Castleark Management LLC with notifications on news.